24.11.2012 Views

Welcome to SBS 2011 - SLAS

Welcome to SBS 2011 - SLAS

Welcome to SBS 2011 - SLAS

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Gaylord Palms Resort and Convention Center | March 27–31, <strong>2011</strong> | Orlando, Florida, USA<br />

Scientific Committee and <strong>SLAS</strong> Leadership<br />

<strong>SBS</strong> <strong>2011</strong> Scientific Committee<br />

Program Chairs<br />

Paul Bernasconi, Ph.D.<br />

BASF Corporation<br />

Peter Hodder, Ph.D.<br />

The Scripps Research Institute<br />

Roger Bosse, Ph.D., PerkinElmer<br />

Paul Burn, Ph.D., Sanford Project<br />

Sabrina Corazza, Ph.D., Axxam SpA<br />

Claude DuFresne, Ph.D., Merck<br />

Ken Duncan, Ph.D., Bill and Melinda Gates Foundation<br />

Achim Grenz, Ph.D., F. Hoffmann-La Roche Ltd<br />

Bob Hertzberg, Ph.D., GlaxoSmithKline<br />

Keith Houck, Ph.D., Environmental Protection Agency<br />

Jim Inglese, Ph.D., NIH Chemical Genomics Center<br />

Bill Janzen, Ph.D., University of North Carolina at<br />

Chapel Hill<br />

Scott Martin, Ph.D., St. Louis University<br />

Jonathan O’Connell, Ph.D., Bris<strong>to</strong>l-Myers<br />

Squibb Company<br />

Ulrich Schopfer, Ph.D., Novartis Institutes for<br />

BioMedical Research<br />

Daniel Sipes, Ph.D., Genomics Institute of the<br />

Novartis Research Foundation<br />

Andrew Su, Ph.D., Genomics Institute of the<br />

Novartis Research Foundation<br />

Phil Tagari, Ph.D., Amgen<br />

Poster Co-Chairs<br />

Julio Martin, GlaxoSmithKline<br />

Julie Li, Sanofi Aventis<br />

<strong>SLAS</strong> Board of Direc<strong>to</strong>rs<br />

Michelle Palmer, Ph.D., Broad Institute of Harvard and MIT<br />

Jason Abbas, M.S., Syngenta Seeds<br />

Robert Ames, Ph.D., GlaxoSmithKline<br />

David Dorsett, M.B.A., Bris<strong>to</strong>l-Myers Squibb Company<br />

Bill Janzen, Ph.D., University of North Carolina - Chapel Hill<br />

Jeff Paslay, Ph.D., Paslay Consulting<br />

Erik Rubin, Ph.D., Bris<strong>to</strong>l-Myers Squibb Company<br />

Mary Jo Wildey, Ph.D., Merck Research Labs<br />

Andy Zaayenga, Ph.D., HighRes Biosolutions<br />

Biomolecular Sciences<br />

Section (BSS) Executive<br />

Council<br />

Sue Holland-Crimmin, Ph.D., GlaxoSmithKline<br />

Lorenz Mayr, Ph.D., Novartis Pharma<br />

Steve Rees, Ph.D., GlaxoSmithKline<br />

Melvin Reichman, Ph.D., Lankenau Institute for<br />

Medical Research Chemical Genomics Center<br />

John Wang, Ph.D., Wang Consulting<br />

Andy Zaayenga, Ph.D., HighRes Biosolutions<br />

Labora<strong>to</strong>ry Au<strong>to</strong>mation<br />

Section (LAS) Executive<br />

Council<br />

Chris Detter, Ph.D., Los Alamos National Labora<strong>to</strong>ry<br />

Hansjörg Haas, Ph.D., Thermo Fisher Scientific<br />

R. Scott Martin, Ph.D., Saint Louis University<br />

Robyn Rourick, M.S., Genentech<br />

Craig Schulz, Ph.D., Amgen<br />

Nitin Sood, M.S., Agilent Technologies<br />

<strong>SLAS</strong>.org/events/sbs11 | 5

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!